Product Reports Resources Pricing Login Book a demo

Impress

Health Tech & Medtech · Barcelona, Spain · Founded 2019

Hybrid, tech-driven clear orthodontic aligner treatments

Valuation $500M–1B
Revenue $10–50M
Headcount 1–2k
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Impress and the history behind them.
Power Law Thoroughbred$100M+ revenue

Talent graph

Impress's talent

Book a demo to see the people
Employees mapped 1,027 incl. 4 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 12 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

14 investors on Impress's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 3 investors entered at this stage
Bynd Venture Capital
Sabadell Venture Capital
TA Ventures
Series A 6 investors entered at this stage
Hillhouse Capital
SHAPE Capital Partners
CareCapital
Nickleby Capital
Michael Linse
Elliot Dornbusch
Series B+ 5 investors entered at this stage
Media Digital Ventures
LBO France
Trinity Capital
Claret Capital Partners
Norgine Ventures

Global footprint

Where Impress has talent and traffic

Workforce by country
28 countries with
team presence
🇪🇸 Spain62.3%
🇵🇹 Portugal8.5%
🇮🇹 Italy6.6%
🇬🇧 United Kingdom3.2%
🇫🇷 France3.1%
Top 5 of 28 shown
Web traffic by country
330K monthly visits
across markets
🇮🇹 Italy47.2%
🇺🇸 United States7.8%
🇪🇸 Spain5.7%
🇺🇦 Ukraine5.3%
🇩🇪 Germany4.3%
Top 5 markets shown

Capital deployed

Impress's 3 investments and acquisitions.

Every disclosed deal where Impress appeared as a backer or acquirer, 2022–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Impress's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Impress's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Impress

        An AI-synthesized read of the highest-engagement posts about Impress on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Impress on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles